SNCA was found to be downregulated in WS-treated neuroblastoma cells pointing to the role of WS in SNCA downregulation, thus highlighting its role in the suppression of Parkinson’s disease (Siddiqui et al., 2016). This evidence concerns the gene SNCA and neuroblastoma.